This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Santen Pharmaceutical Co., Ltd., Other. Active years: 2007-2012.
Company Filing History:
3 out of 282 
3 out of 834,350 Years Active: 2007-2012
Title: Makoto Inui: Innovator in Therapeutic Peptides
Introduction
Makoto Inui is a notable inventor based in Ube, Japan. He has made significant contributions to the field of therapeutic peptides, holding a total of 3 patents. His work focuses on innovative methods for treating skin wounds and corneal disorders.
Latest Patents
Inui's latest patents include groundbreaking methods for treating skin wounds. One patent describes a therapeutic method that involves administering a composition containing specific peptides to patients in need. The first peptide consists of the amino acid sequence represented by Ser-Ser-Ser-Arg, while the second peptide is represented by Phe-Gly-Leu-Met-NH. Both peptides are combined with pharmaceutically acceptable additives to enhance their effectiveness.
Another patent focuses on treating corneal disorders and promoting skin wound healing. This method also involves administering a composition containing the same peptides, along with a pharmaceutically acceptable carrier. These innovations highlight Inui's commitment to advancing medical treatments through peptide technology.
Career Highlights
Throughout his career, Makoto Inui has worked with Santen Pharmaceutical Co., Ltd., where he has contributed to various research and development projects. His expertise in peptide therapeutics has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Inui has collaborated with notable colleagues, including Teruo Nishida and Masatsugu Nakamura. These partnerships have fostered a collaborative environment that encourages innovation and the development of new therapeutic solutions.
Conclusion
Makoto Inui's contributions to the field of therapeutic peptides are significant and impactful. His innovative methods for treating skin wounds and corneal disorders demonstrate his dedication to improving patient care through scientific advancements.